Ritonavir Recruiting Phase 2 Trials for Novel Coronavirus Infectious Disease (COVID-19) / Novel Coronavirus Infection Treatment

clinicaltrials.gov IdentifierTitleDrugs
NCT04276688Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment
NCT04372628Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19
NCT04330690Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial
NCT04321993Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients